Extracellular matrix (ECM) is primarily composed of collagen, glycoproteins (such as laminin, vitronectin, and fibronectin), and proteoglycans. It is crucial for stem cell adhesion and tissue stability by activating signaling pathways through integrins. For effective use in regenerative medicine and cell therapy, chemically defined, non-xenogeneic, reproducible, and scalable culture conditions are required. This is typically achieved by adding specific ECM components into the culture system, providing a stable environment essential for stem cell survival.
Under a well-established cell culture platform and stringent quality management system, we proudly launch our PG-grade and GMP-grade Laminin, Fibronectin, Vitronectin, and other ECM protein products. These provide an optimal extracellular matrix microenvironment for stem cells such as hPSCs and MSCs, supporting the entire workflow from early-stage R&D to clinical translation.
Moreover, our Laminin products strictly adhere to internationally leading viral safety control standards, implementing a comprehensive safety assurance system through five core strategies:

Rigorous Cell Bank Testing
Comprehensive testing (28 items) of the adapted and banked production host cell line, performed by internationally renowned third-party testing agencies in compliance with US and Chinese Pharmacopoeia standards and ICH Q5.
Animal-Origin-Free (AOF) Production Process
Upstream culture uses chemically defined medium (CDM), with all raw materials being serum-free (SF) and animal-origin-free (AOF), thoroughly eliminating the risk of animal-derived viral contamination.
Dual Virus Reduction Measures
Incorporation of viral clearance/inactivation steps such as low-pH treatment and nanofiltration in the downstream purification process.
Comprehensive Viral Clearance Validation
Validation of key viral removal steps through dedicated viral clearance studies.
Stringent Final Product Quality Control and Release
Products undergo testing for adventitious agents, multiple process-related impurities, and a total of 13–16 QC release tests.
We provide a comprehensive selection of validated, high-activity extracellular matrix proteins, including Laminin, Vitronectin, and Fibronectin. These proteins are specifically designed to support a wide range of stem cell culture requirements and have been tested to ensure they meet the highest standards, offering exceptional performance and reliability for diverse applications in stem cell research and therapy.
| Matrix Proteins | Catalog No. | Product | Application |
|---|---|---|---|
| Laminin 521 | GMP-LA5H24GA02 | GMP Human Laminin 521 Protein (Liquid) | Human PSC expansion in the clinical stage |
| GMP-LA5H24 | GMP Human Laminin 521 Protein | Human PSC expansion in the clinical stage | |
| LA5-H5213L | Human Laminin 521 Protein, premium grade (Liquid) | Human PSC expansion in the pre-clinical stage | |
| LA5-H5261 | Human Laminin 521 Protein, premium grade | Human PSC expansion in the pre-clinical stage | |
| LA5-H5248 | Human Laminin 521 Protein, premium grade (Flagship) | Human PSC expansion in the pre-clinical stage | |
| Laminin 511 | GMP-LA1H36 | GMP Human Laminin 511 Protein (Mix & Scale) | Human PSC expansion in the clinical stage |
| GMP-LA1H25 | GMP Human Laminin 511 Protein | Human PSC expansion in the clinical stage | |
| LA1-H5314 | Human Laminin 511 Protein, premium grade (Mix & Scale) | Human PSC expansion in the pre-clinical stage | |
| LA8-H5283L | Human Laminin 511 Protein, premium grade | Human PSC expansion in the pre-clinical stage | |
| Vitronectin | GMP-VINH19 | GMP Human Truncated Vitronectin / VTN-N Protein | Human PSC expansion in the clinical stage |
| VIN-H5117 | Human Truncated Vitronectin / VTN-N Protein, premium grade | Human PSC expansion in the pre-clinical stage | |
| Fibronectin | GMP-FINH18 | GMP Recombinant Human Fibronectin fragment | Mesenchymal stem cell attachment and proliferation |
| FIN-H5116 | Recombinant Fibronectin fragment, premium grade | Mesenchymal stem cell attachment and proliferation | |
| Laminin 111 | LA1-H5269 | Human Laminin 111 Protein, premium grade | Hepatic and neural differentiation |
| Laminin 121 | LA1-H5261 | Human Laminin 121 Protein, premium grade | Especially hepatic and neural cells among many other cell types |
| Laminin 211 | LA8-H5263 | Human Laminin 211 Protein, premium grade | Skeletal muscle, neural and cardiac cells differentiation |
| Laminin 221 | LA2-H5269 | Human Laminin 221 Protein, premium grade | Cardiac cells differentiation |
| Laminin 411 | LAT-H5263 | Human Laminin 411 Protein, premium grade | Endothelial and pancreatic cells differentiation |
Can't find the
Product you need?
Delivering high-quality GMP products at an affordable cost lowers barriers to accessing innovative medicines, including cell therapies. Transitioning from our premium (Pre-GMP) grade products to GMP requires minimal comparability testing. Our premium-grade products have validated equivalent bioactivity and consistency and are manufactured using the same methods and processes. Learn more about GMP vs Premium Grade
Empowering Academia — Research Grade Human Laminin 521 Protein
We are now offering a special promotion of Research Grade (RG) Human Laminin 521, exclusively for our academic customers. This initiative is a token of our gratitude for the extensive support from research institutions and aims to further advance foundational stem cell research. RG Laminin 521 is now available at a more affordable price, and we welcome your inquiries and orders.
Laminin 521 (GMP-LA5H24) effectively maintains the expansion of human iPSCs.
Laminin 521 (GMP-LA5H24) could maintain the stemness of iPSC after several passages.
Normal karyotype (46, XX) was found in hiPSCs with Laminin 521(GMP-LA5H24) coating after 10 passages.
GMP Recombinant Human Fibronectin fragment (Cat. No. GMP-FINH18) could promote mesenchymal stem cell attachment and proliferation in several passages, comparable with Competitor T. The bioactivity of GMP Recombinant Human Fibronectin fragment (Cat. No. GMP-FINH18) is similar to Recombinant Fibronectin fragment, premium grade (Cat. No. FIN-H5116).
GMP Recombinant Human Fibronectin fragment (Cat. No. GMP-FINH18) could maintain the stemness of MSC in several passages, with high expression of MSC markers CD73, CD90 and CD105 and negative expression of HLA-DR, CD34 and CD45. The stemness ability of GMP Recombinant Human Fibronectin fragment (Cat. No. GMP-FINH18) is comparable with Competitor T and similar to Recombinant Fibronectin fragment, premium grade (Cat. No. FIN-H5116).
CD34+ CD45+ hematopoietic cells were seeded on GMP Recombinant Human Fibronectin fragment (Cat. No. GMP-FINH18) combined with GMP Human DLL4 Protein, Fc Tag (Flagship) (Cat. No. GMP-DL4H27) and GMP Human VCAM-1 Protein, Fc Tag (Cat. No. GMP-VC1H25) coated plates and differentiated for 21 days, then flow cytometry was used to detect the expression of T-cell progenitor markers, CD5 and CD7. GMP Recombinant Human Fibronectin fragment (Cat. No. GMP-FINH18) combined with GMP Human DLL4 Protein, Fc Tag (Flagship) (Cat. No. GMP-DL4H27) and GMP Human VCAM-1 Protein, Fc Tag (Cat. No. GMP-VC1H25) can induce the formation of CD7+ and CD5+ CD7+ T-cell progenitors. The bioactivity of GMP Recombinant Human Fibronectin fragment (Cat. No. GMP-FINH18) is similar to Recombinant Fibronectin fragment, premium grade (Cat. No. FIN-H5116), as well as the competitor T. Negative control: w/o Human Fibronectin.
Interested in testing
a GMP grade product?
For academic customers, we recommend research grade Laminin 521, which is suited for stem cell research and high affordable compared to other commercial extracellular cell matrixes. GMP grade laminin 521 is designed for large scale manufacturing process of iPSC in the clinical stage, which is produced under strict GMP systems and comply with regulations from multiple countries.
Recombinant Laminin 521 is the defined cell matrix with good lot-to-lot consistency. It supports faster stem cell growth in monogenous monolayer compared to basement membrane extracts. It is widely used for in vitro feeder-free culture of multiple human pluripotent stem cells and maintain the high quality.
No more special adaption process is needed when you transfer your stem cells from other commercial extracellular matrix proteins, such as Matrigel, Vitronectin and other Laminin proteins to our Laminin 521 protein. We recommend adapting your stem cells by at least 2 passages and adding Rock inhibitor (such as Y-27632). If it is hard to adapt, the higher working concentration of Laminin 521 protein (such as 10 μg/ml) is recommended. After several passages, if your stem cells are well adapted, you can reduce the working concentration and cell density.
We have tried different dissociation enzymes, such as EDTA, Accutase, TrypLE Select to passage iPSC. Generally, the incubation time is about 5-6 minutes and will be longer depending on special cell lines. Meanwhile, stem cells coated with Laminin 521 often attach tighter compared to other matrix proteins. The lower working concentration of Laminin protein should be used to reduce the detach time.
Laminin proteins are crucial for stem cell expansion and defined cell differentiation based on the expression in different tissues in human body. For human pluripotent stem cell culture, Laminin 521 and Laminin 511 are recommended for the expansion of high-quality stem cells. Laminin 111 and Laminin 121 are used in hepatic and neural cell differentiation. Laminin 211 could support skeletal muscle, neural and cardiac cells differentiation. Laminin 411 is used in endothelial and pancreatic cells differentiation.